Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA – Get Free Report) have earned an average recommendation of “Moderate Buy” from the seven brokerages that are presently covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $19.33.
SBRA has been the topic of several recent analyst reports. Mizuho reaffirmed a “neutral” rating and set a $20.00 target price on shares of Sabra Health Care REIT in a research note on Thursday, December 5th. Citizens Jmp raised Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, January 7th. JMP Securities raised Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price objective for the company in a research report on Tuesday, January 7th. Finally, Truist Financial boosted their price target on Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a “hold” rating in a research report on Tuesday, March 18th.
Read Our Latest Stock Analysis on Sabra Health Care REIT
Sabra Health Care REIT Trading Down 0.4 %
Sabra Health Care REIT (NASDAQ:SBRA – Get Free Report) last announced its quarterly earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.36. The business had revenue of $182.35 million for the quarter, compared to the consensus estimate of $178.01 million. Sabra Health Care REIT had a return on equity of 4.60% and a net margin of 18.02%. On average, analysts predict that Sabra Health Care REIT will post 1.45 EPS for the current year.
Sabra Health Care REIT Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Friday, February 14th were paid a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 6.95%. The ex-dividend date of this dividend was Friday, February 14th. Sabra Health Care REIT’s dividend payout ratio is 226.42%.
Institutional Trading of Sabra Health Care REIT
A number of hedge funds and other institutional investors have recently modified their holdings of the stock. JPMorgan Chase & Co. boosted its stake in shares of Sabra Health Care REIT by 222.4% in the third quarter. JPMorgan Chase & Co. now owns 9,886,917 shares of the real estate investment trust’s stock valued at $183,996,000 after buying an additional 6,819,919 shares during the period. Norges Bank bought a new stake in shares of Sabra Health Care REIT in the fourth quarter worth $48,950,000. Wellington Management Group LLP boosted its position in Sabra Health Care REIT by 736.5% during the third quarter. Wellington Management Group LLP now owns 2,396,835 shares of the real estate investment trust’s stock valued at $44,605,000 after acquiring an additional 2,110,307 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in Sabra Health Care REIT by 324.3% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,404,576 shares of the real estate investment trust’s stock valued at $26,139,000 after acquiring an additional 1,073,530 shares during the last quarter. Finally, Northern Trust Corp boosted its position in Sabra Health Care REIT by 27.7% during the fourth quarter. Northern Trust Corp now owns 4,169,385 shares of the real estate investment trust’s stock valued at $72,214,000 after acquiring an additional 905,466 shares during the last quarter. Institutional investors and hedge funds own 99.40% of the company’s stock.
About Sabra Health Care REIT
Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
Featured Stories
- Five stocks we like better than Sabra Health Care REIT
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
- With Risk Tolerance, One Size Does Not Fit All
- 3 ETFs to Ride the VIX Surge During Market Volatility
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Why Williams-Sonoma Will Hit Fresh Highs in 2025
Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.